Core Viewpoint - NeuroOne Medical Technologies Corporation is set to provide an overview of its business model and anticipated revenue growth for fiscal year 2025, following a significant increase in product revenue in fiscal year 2024 [1][2]. Group 1: Business Model and Revenue Growth - The company has recently expanded its exclusive distribution agreement with Zimmer Biomet, a leading medical device manufacturer [2]. - Product revenue for fiscal year 2024 grew by 77% to 8 million and $10 million in fiscal year 2025, indicating a growth of 132% to 190% [2]. Group 2: Upcoming Investor Webinar - A virtual investor webinar is scheduled for January 10, 2025, where the CEO will present the business model and recent achievements, followed by a Q&A session [3]. - Participants are encouraged to join at least five minutes early to ensure timely participation [3]. Group 3: Company Overview - NeuroOne is focused on developing minimally invasive and high-definition solutions for EEG recording, brain stimulation, and ablation for various neurological disorders, aiming to improve patient outcomes and reduce procedural costs [5]. - The company may also explore applications in other areas such as depression, mood disorders, and artificial intelligence [5].
NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024